Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Protein kinase domain containing protein | 0.0029 | 0.0069 | 1 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0029 | 0.0069 | 0.0069 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0069 | 1 |
Toxoplasma gondii | PAN domain-containing protein | 0.0296 | 0.7103 | 1 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0029 | 0.0069 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0029 | 0.0069 | 1 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0029 | 0.0069 | 1 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0029 | 0.0069 | 1 |
Toxoplasma gondii | PAN domain-containing protein | 0.0296 | 0.7103 | 1 |
Brugia malayi | Kringle domain containing protein | 0.0029 | 0.0069 | 1 |
Onchocerca volvulus | 0.0029 | 0.0069 | 0.5 | |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0029 | 0.0069 | 0.5 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0029 | 0.0069 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0029 | 0.0069 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.